Literature DB >> 33651326

Predictors of post-traumatic complication of mild brain injury in anticoagulated patients: DOACs are safer than VKAs-comment.

Gianni Turcato1, Arian Zaboli2, Elisabetta Zorzi3, Giorgio Ricci4, Antonio Bonora4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33651326     DOI： 10.1007/s11739-021-02687-y

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

Review 1.  Direct oral anticoagulants: evidence and unresolved issues.

Authors:  Noel Chan; Magdalena Sobieraj-Teague; John W Eikelboom
Journal:  Lancet       Date:  2020-11-28       Impact factor: 79.321

2.  Predictors of post-traumatic complication of mild brain injury in anticoagulated patients: DOACs are safer than VKAs.

Authors:  Alessandro Cipriano; Naria Park; Alessio Pecori; Alessandra Bionda; Michele Bardini; Francesca Frassi; Valentina Lami; Francesco Leoli; Maria Laura Manca; Stefano Del Prato; Massimo Santini; Lorenzo Ghiadoni
Journal:  Intern Emerg Med       Date:  2021-01-01       Impact factor: 3.397

3.  Risk of significant traumatic brain injury in adults with minor head injury taking direct oral anticoagulants: a cohort study and updated meta-analysis.

Authors:  Gordon Fuller; Lisa Sabir; Rachel Evans; Daniel Bradbury; Maxine Kuczawski; Suzanne M Mason
Journal:  Emerg Med J       Date:  2020-09-08       Impact factor: 2.740

4.  Thirty-day mortality in atrial fibrillation patients with gastrointestinal bleeding in the emergency department: differences between direct oral anticoagulant and warfarin users.

Authors:  Gianni Turcato; Antonio Bonora; Elisabetta Zorzi; Arian Zaboli; Massimo Zannoni; Giorgio Ricci; Norbert Pfeifer; Antonio Maccagnani; Andrea Tenci
Journal:  Intern Emerg Med       Date:  2019-11-21       Impact factor: 3.397

5.  Trends in anticoagulant prescribing: a review of local policies in English primary care.

Authors:  Katherine H Ho; Maria van Hove; Gillian Leng
Journal:  BMC Health Serv Res       Date:  2020-04-03       Impact factor: 2.655
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.